← Open Payments lookup

HEATH LINDSEY: Open Payments

NPI 1578048708 · SHOW LOW, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$922 in 49 payments from 12 companies in 2025. Trend: 2023 $362 · 2024 $438 · 2025 $922

Food & beverage: $922
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$195
Teva Pharmaceuticals USA, Inc.11$167
Otsuka America Pharmaceutical, Inc.9$166
Janssen Pharmaceuticals, Inc4$103
GlaxoSmithKline, LLC.4$76
Alkermes, Inc.3$72
Vanda Pharmaceuticals Inc.2$36
AstraZeneca Pharmaceuticals LP2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
Exact Sciences Corporation1$20

Products named: INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, TRELEGY ELLIPTA, LYBALVI, SPRAVATO, INVEGA SUSTENNA, UZEDY.

Industry payments across AZ — which companies pay providers there.